Peter Virsik - Feb 5, 2024 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Signature
/s/ Peter Virsik
Stock symbol
EPIX
Transactions as of
Feb 5, 2024
Transactions value $
-$9,825
Form type
4
Date filed
2/6/2024, 08:27 AM
Previous filing
Jan 17, 2024
Next filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPIX Common Shares Sale -$6.42K -694 -4.95% $9.25 13.3K Feb 5, 2024 Direct F1
transaction EPIX Common Shares Options Exercise $1.62K +500 +3.75% $3.23 13.8K Feb 5, 2024 Direct F1
transaction EPIX Common Shares Sale -$5.02K -500 -3.62% $10.04 13.3K Feb 5, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EPIX Options Options Exercise $0 -500 -0.05% $0.00 968K Feb 5, 2024 Common Shares 500 $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects a transaction effected pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.